Rissler K, Cramer H, Engelmann P
University of Freiburg, Department of Neurology, Germany.
J Chromatogr B Biomed Sci Appl. 1997 Sep 26;698(1-2):17-26. doi: 10.1016/s0378-4347(97)00278-8.
Radiolabeling of [Tyr8]-substance P ([Tyr8]-SP) with the (125)I-isotope was performed by use of the chloramine-T technique. The primary formed radiolabeled product, having been quantitatively converted to the corresponding sulfoxide yielding [(125)I]-[Tyr8]-(Met11-->O)-SP completely lacked any binding to proteins rich in SP receptor populations. However, after reductive treatment with mercaptoethanol for about 2 h, a complete reconstitution of the Met11 thioether structure was observed. The reduced peptide, consisting of [(125)I]-[Tyr8]-(Met11)-SP was separated from its by-products by reversed-phase high-performance liquid chromatography on octadecylsilyl silica gel with 100 mM triethyl ammonium formate buffer containing 22% acetonitrile (pH 2.2). The labeled SP derivative prepared by this two-step synthesis was obtained in 73% overall yield related to the [Tyr8]-SP starting material and exhibited a specific activity of 1.9-10(6) Ci/M. In contrast to [(125)I]-[Tyr8]-->(Met11-->O)-SP, satisfactory receptor-binding was now observed with the [(125)I]-->[Tyr8]-(Met11)-SP derivative.
采用氯胺 - T 技术用(125)I 同位素对 [Tyr8] - 速激肽([Tyr8] - SP)进行放射性标记。最初形成的放射性标记产物经定量转化为相应的亚砜,生成 [(125)I] - [Tyr8] - (Met11→O) - SP,该产物与富含 SP 受体群体的蛋白质完全没有任何结合。然而,在用巯基乙醇还原处理约 2 小时后,观察到 Met11 硫醚结构完全重构。还原后的肽,即 [(125)I] - [Tyr8] - (Met11) - SP,通过在十八烷基硅烷硅胶上进行反相高效液相色谱法,使用含有 22%乙腈(pH 2.2)的 100 mM 甲酸三乙铵缓冲液,从其副产物中分离出来。通过这种两步合成法制备的标记 SP 衍生物,相对于 [Tyr8] - SP 起始原料,总产率为 73%,比活为 1.9×10^6 Ci/mmol。与 [(125)I] - [Tyr8] - (Met11→O) - SP 相反,现在观察到 [(125)I] - [Tyr8] - (Met11) - SP 衍生物具有令人满意的受体结合能力。